First reported 10 hours ago -
Updated 10 hours ago -
1 reports
Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced three presentations demonstrating the superiority of the AE37 breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). ...
[Published Zecco - 10 hours ago]